Clinical Research Trials of Florida, Inc.

Tampa, Florida 33607

2 studies enrolling now · 21 studies all time

What they study most

Acne Vulgaris, Alopecia Areata, Asthma, Atopic Dermatitis, Atopic Dermatitis Eczema, COVID-19 Disease, Chronic Idiopathic Constipation, Chronic Obstructive Pulmonary Disease, Coronavirus Infection, Dermatitis, Atopic, Gout, Gout Flare

Studies at this site

• Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease — Recruiting now
• A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis — Stopped early
• A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma — Completed
• Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis — Completed
• A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia — Completed
• Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata — Running, not enrolling
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) — Completed
• B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis — Completed
• Phase 2 Dose-finding IMU-838 for Ulcerative Colitis — Stopped early
• Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure — Stopped early
• A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD — Completed
• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) — Completed
• Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis — Completed
• Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy — Completed
• GB001 in Adult Subjects With Moderate to Severe Asthma — Completed
• Genomics Used to Improve DEpression Decisions — Completed
• Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris — Completed
• Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma — Completed
• A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation — Completed